TCL Archive Conferees Set $1.991 Bil. NCI Budget, Ax Earmark For Breast Cancer, But Find $210 Mil. In Defense October 9, 1992
TCL Archive FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight December 17, 2010
TCL Archive In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs June 18, 1982
TCL Archive Investigation finds no evidence FDA’s Crawford had affair with subordinate. June 10, 2005